Chemotherapy & Radiation

In the Phase I trial, newly diagnosed patients are enrolled to one of two regimens evaluating ADCETRIS administered either sequentially with CHOP or concurrently with CH-P, which removes vincristine from the regimen: The...

The study has enrolled 41 patients who progressed on at least one prior chemotherapy regimen that included a platinum compound, or cisplatin, oxaliplatin, or carboplatin, and a fluoropyrimidine compound, or 5-fluorouracil [5-FU] or...

The week 12 disease control rate (PR and SD at week 12) was 68%. Evidence of objective tumor regression was observed in 78% of patients, including those with or without prior sorafenib therapy....

NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated license agreement with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company, while...

Last January Marc Alessi was tapped to lead the Long Island Angel Network as it sought to help finance startups that would hopefully grow to become the region's largest corporations. Now he has...

-- Test Associated with Changes in Treatment Management in 65% of Patients with Difficult-to-Diagnose Cancers -- REDWOOD CITY, Calif. -- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their...

MAUI, Hawaii -- At Retina Meeting 2012 today, Reid Schindler, M.D., presented positive Phase I data from a human study designed to assess a new investigational therapy to treat Wet Age-related Macular Degeneration...

BALERNA, Switzerland -- APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm[TM] Ondansetron...

Former Northwest Hospital & Medical Center COO Joins North Seattle Proton Therapy Center Opening in Spring 2013 SEATTLE -- ProCure Treatment Centers, Inc., (ProCure) and Seattle Cancer Care Alliance (SCCA) have named Annika...

ROCHESTER, Minn. -- An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/d8ccf2/aesthetic_and_reco) has announced the addition of the "Aesthetic and Reconstructive Breast Surgery: Solving Complications and Avoiding Unfavorable Results" book to their offering. Breast surgery - both for elective...

SALT LAKE CITY -- BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.bsdmedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the purchase, installation and acceptance of...

BERLIN -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/db4820/oncology_devices_m) has announced the addition of the "Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment" report to...

EXTON, Pa. -- BioTrends Research Group, LLC has released findings from the LaunchTrends([R]): Zytiga report, the first in a three-wave series. The study was conducted with 106 U.S. urologists and medical oncologists about...

BOTHELL, Wash. -- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced updates to the U.S. Prescribing Information (PI) for ADCETRIS[TM] (brentuximab vedotin). The revised PI will include the following updated information: * A boxed...

MARBLEHEAD, Mass. -- Medicinal Genomics, a pioneer in the genomics of medicinal plants, today announced the availability of Jane-Ome, an application designed for Apple's iPad tablet, which offers a science-based dissection of medical...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a2e214/oncology_therapeut) has announced the addition of the "Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development"...

COLORADO SPRINGS, Colo. -- Cannabis Science, Inc. (OTCBB: CBIS.OB - News), a pioneering US biotech company developing pharmaceutical cannabis products, is happy to report an additional, apparently successful, self-medicated cannabis treatment for a...